UpdatesGeneral Updates
Borosil Scientific released its Q3 and 9MFY26 investor presentation.
Borosil Scientific LimitedBOROSCI · Filed with the exchange
Consolidated EBITDA for 9MFY26 declined due to lower sales in Goel Scientific.
The company targets 12-14% revenue CAGR and improved EBITDA margins, emphasizing 'Make in India' and exports.
No comments yet. Be the first.